Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03102580 · ClinicalTrials.gov registry record · NA
Development of an Osteoarthritis (OA) Care Plan to Improve Process and Quality of OA Treatment Decisions
A NA study, sponsored by University of Massachusetts, Worcester.
- Completed
- Registry status
- NA
- Development phase
- 5,713
- Enrollment target
NCT03102580: Completed NA study, sponsored by University of Massachusetts, Worcester.
NCT03102580 is a NA study that has completed, run by University of Massachusetts, Worcester. The registered enrollment target is 5,713 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (307% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03102580, a NA study, has completed, sponsored by University of Massachusetts, Worcester.
- COMPLETED
- Registry status
- NA
- Development phase
- 5,713 participants
- Enrollment target
Study Summary
Knee and hip osteoarthritis (OA) is the most common cause of disability in the U.S. and affects more than 60% of adults over 65 years. As the burden of knee and hip OA increases among aging adults, more patients are deciding to have joint replacement surgery. However, no clear guidelines exist for patients to determine if or when to undergo total joint replacement (TJR). The investigators plan to develop a web-based system that will provide individualized patient OA Care Plans that will help patients make informed decisions about how to treat their arthritis. The investigators will be using this system with patients to see if they find it useful. The investigators believe that the OA Care plan will improve the process and quality of OA treatment decisions and the quality of OA care.
Primary Outcome
The Decision Conflict Scale (DCS) is a validated self-report instrument that assesses uncertainty in healthcare decision making. The DCS consists of 16 items, each rated on a 5-point Likert scale. Scores are summed and transformed to a total score from 0 (no conflict) to 100 (high conflict). Lower scores indicate less decisional conflict (better outcome), and higher scores reflect greater decisional conflict (worse outcome). Mean (standard deviation) DCS scores are reported by study arm/group.
Interventions
- OTHER OA Care Plan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,713 participants |
| Start Date | 2017-11-01 |
| Est. Completion | 2023-04-04 |
| Phase | NA |
What the finished NCT03102580 record still lists
NCT03102580 is an interventional study that assigns participants to a tested intervention. Its 5,713 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (307% higher).
The record links to 0 conditions, and to 1 intervention - of which OA Care Plan is the first listed.
NCT03102580 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03102580 about?
NCT03102580 is a clinical study titled "Development of an Osteoarthritis (OA) Care Plan to Improve Process and Quality of OA Treatment Decisions". Knee and hip osteoarthritis (OA) is the most common cause of disability in the U.S. and affects more than 60% of adults over 65 years. As the burden of knee and hip OA increases among aging adults, more patients are deciding to have joint replacement surgery. However, no clear guidelines exist for p...
What is the current status of trial NCT03102580?
This trial is currently completed. It is a NA study. The enrollment target is 5,713 participants. The study started on 2017-11-01. Estimated completion is 2023-04-04.
What interventions are being tested in trial NCT03102580?
The interventions under investigation include: OA Care Plan (OTHER).
Who is sponsoring clinical trial NCT03102580?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03102580's enrollment target sits among peer trials
5,713 24th of 2000 higher than 1,977 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04983875 · 5,708 participants · NA
Mammography and Breast Arterial Calcification: An Information-Sharing Trial
- NCT06627335 · 5,621 participants
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis
- NCT05636176 · 5,600 participants · Phase 3
A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation
- NCT06981598 · 5,586 participants · NA
Prevention of Psychological Health Problems Via Integrated Operational Support
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI